Overview
Total raised
$87.5M
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 11, 2011 | Funding round | $20M |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 4, 2012 | New broad-spectrum antibiotic based on Nobel Prize-winning research reaches phase 3 | The drug has been tested in more than 1,200 patients in four phase 2 trials, where it’s shown promising results in the treatment of pneumonia, bronchitis and skin infections. It’s being developed in oral and IV formulations so that patients... |
| Nov 30, 2012 | Rib-X Pharmaceuticals Closes First Tranche of $67.5M Series 2 Financing | Rib-X Pharmaceuticals, Inc., a New Haven, CT-based biopharmaceutical company developing new antibiotics for the treatment of serious and life-threatening infections, has closed the first tranche of a $67.5m Series 2 financing. The round was... |
| Nov 29, 2012 | Rib-X Closes First Tranche in $67.5M Series 2 | NEW HAVEN, CT, Rib-X Pharmaceuticals, Inc. today announced that it has closed the first tranche of a $67.5 million Series 2 preferred stock financing. The round was led by new investor Vatera Healthcare Partners. >> Click here for ... |
| Jan 11, 2011 | Rib-X Pharmaceuticals Raises $20M | Rib-X Pharmaceuticals, Inc., a New Haven, CT-based company that develops broad spectrum antibiotics, has raised $20m in funding. The financing was led by existing investor Warburg Pincus LLC. The company intends to use the funds to support ... |
| New broad-spectrum antibiotic based on Nobel Prize-winning research reaches phase 3 | Three years ago, Yale University professor of molecular biophysics and biochemistry Thomas Steitz won the Nobel Prize in chemistry for his research on the structure and function of the ribosome. Now, the company that he co-founded to create... | |
| They’re not yet Bostons, but these 5 areas are growing into hubs for life sciences innovation | Boston might be the top hub for life sciences in the U.S., but there are lots of cities hot on its tail. In addition to ranking the top 10 clusters for life sciences in 2012, an annual report from Jones Lang LaSalle’s highlighted some fast-... |